Shirong Cai

6PUBLICATIONS
58CO-AUTHORS
Cancer cell biologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 24, 2025
Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion.

Tianhao Zhang, Ying Li, Ertao Zhai

|Oct 18, 2024
Tumor-secreted LCN2 impairs gastric cancer progression via autocrine inhibition of the 24p3R/JNK/c-Jun/SPARC axis.

Zhixin Huang, Ying Li, Yan Qian

|Mar 29, 2024
BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers.

Guang Lei, Chao Mao, Amber D Horbath

|Nov 30, 2023
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors: A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 Studies.

Michael C Heinrich, Xinhua Zhang, Robin L Jones

|Feb 04, 2023
Spindle function and Wnt pathway inhibition by PBX1 to suppress tumor progression via downregulating DCDC2 in colorectal cancer.

Weigang Dai, Yinan Liu, Tianhao Zhang

|Jun 10, 2022
Efficacy and Safety of Ripretinib in Chinese Patients with Advanced Gastrointestinal Stromal Tumors as a Fourth- or Later-Line Therapy: A Multicenter, Single-Arm, Open-Label Phase II Study.

Jian Li, Shirong Cai, Yongjian Zhou

Pageof 1

Frequent Collaborators

3 joint publications

Yinan Liu

3 joint publications

Tianhao Zhang

3 joint publications

Ertao Zhai

3 joint publications

Jianhui Chen